PTD modified paclitaxel anti-resistant liposomes for treatment of drug-resistant non-small cell lung cancer.

about

PTD modified paclitaxel anti-resistant liposomes for treatment of drug-resistant non-small cell lung cancer.

Item

http://www.wikidata.org/entity/Q50646630

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

PTD modified paclitaxel anti-r ...... nt non-small cell lung cancer.

@en

PTD modified paclitaxel anti-r ...... nt non-small cell lung cancer.

@nl

type

Item

label

PTD modified paclitaxel anti-r ...... nt non-small cell lung cancer.

@en

PTD modified paclitaxel anti-r ...... nt non-small cell lung cancer.

@nl

prefLabel

PTD modified paclitaxel anti-r ...... nt non-small cell lung cancer.

@en

PTD modified paclitaxel anti-r ...... nt non-small cell lung cancer.

@nl

P1476

PTD modified paclitaxel anti-r ...... nt non-small cell lung cancer.

@en

P2093

Cui-Qing Li

http://www.w3.org/2001/XMLSchema#string

Lan Cheng

http://www.w3.org/2001/XMLSchema#string

Rui-Jun Ju

http://www.w3.org/2001/XMLSchema#string

Xiao-Ming Peng

http://www.w3.org/2001/XMLSchema#string

Xin Wang

http://www.w3.org/2001/XMLSchema#string

Xue-Tao Li

http://www.w3.org/2001/XMLSchema#string

Yao Xiao

http://www.w3.org/2001/XMLSchema#string

P2860

DMXAA causes tumor site-specific vascular disruption in murine non-small cell lung cancer, and like the endogenous non-canonical cyclic dinucleotide STING agonist, 2'3'-cGAMP, induces M2 macrophage repolarization

Multifunctional targeting daunorubicin plus quinacrine liposomes, modified by wheat germ agglutinin and tamoxifen, for treating brain glioma and glioma stem cells

Tat PTD-endostatin: A novel anti-angiogenesis protein with ocular barrier permeability via eye-drops.

Glioma-targeted therapy using Cilengitide nanoparticles combined with UTMD enhanced delivery.

Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter

Afatinib reverses multidrug resistance in ovarian cancer via dually inhibiting ATP binding cassette subfamily B member 1.

Enhanced therapeutic effect of Adriamycin on multidrug resistant breast cancer by the ABCG2-siRNA loaded polymeric nanoparticles assisted with ultrasound

Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer.

GE11-modified liposomes for non-small cell lung cancer targeting: preparation, ex vitro and in vivo evaluation

Targeting vincristine plus tetrandrine liposomes modified with DSPE-PEG2000-transferrin in treatment of brain glioma.

P304

1-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/08982104.2017.1327542

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28480778

http://www.w3.org/2001/XMLSchema#string